01
Understanding iris pigmentation
The Lumineyes™ concept emerged from observing how changes in iris pigmentation can affect light reflection, perceived color and patient comfort.
Dr. Mustafa Mete is an ophthalmologist with 25 years of surgical experience, focused on advanced laser eye surgery, anterior segment assessment and the clinical development of selective laser iris depigmentation.
As the developer of the MyLumineyes™ method, his approach to eye color change is medically guided, non-incisional and centered on patient selection, risk assessment, realistic expectations and long-term follow-up.
The foundations of Dr. Mete’s work developed through ophthalmology training, anterior segment experience, laser-based procedures and long-term clinical observation.
During residency and subsequent clinical practice in Türkiye, Dr. Mete was exposed to a broad range of anterior segment disease, refractive surgery techniques and laser-based treatments. His training included opportunities to observe and collaborate with experienced ophthalmologists, contributing to his understanding of corneal and anterior segment physiology.
Dr. Mete achieved a national ranking in the Turkish Medical Specialty Examination (TUS). His clinical interests evolved across ophthalmic laser applications, near-vision solutions, corneal procedures and the study of iris pigmentation and selective wavelength response.
Clinical experience and procedural observation form part of the background to the MyLumineyes™ approach.
The method developed within an ophthalmic framework that considers anterior segment anatomy, iris pigmentation, ocular findings and the biological variability observed between individual patients.
The MyLumineyes™ concept developed progressively through observation, clinical assessment, staged treatment and long-term follow-up rather than as a single cosmetic intervention.
The Lumineyes™ concept emerged from observing how changes in iris pigmentation can affect light reflection, perceived color and patient comfort.
Cases are evaluated individually, taking into account baseline pigmentation, iris grade, ocular health, patient expectations and relevant clinical findings.
The approach emphasizes a controlled, stepwise process rather than pursuing extreme or unnatural results, with treatment planning adapted to each case.
More than 15 years of clinical experience and long-term patient follow-up have informed observations regarding healing, stability and patient experience.
A video perspective featuring Dr. Mustafa Mete and the clinical development surrounding the MyLumineyes™ approach.
Eye color change is approached as a medical procedure with a cosmetic impact, rather than as a simple cosmetic service.
Clinical suitability is considered before treatment planning.
Ocular health and relevant clinical findings form part of assessment.
Expectations, limitations and relevant risks are discussed before intervention.
Clinical observation continues beyond the treatment session itself.
The MyLumineyes™ approach was developed by ophthalmologist Dr. Mustafa Mete as a staged clinical protocol intended to guide pigment reduction while maintaining attention to ocular safety and the natural anatomy of the iris.
Focused on superficial iris pigment and the interaction of melanin with selected wavelengths.
No artificial material is introduced into the eye as part of the laser-based concept.
Baseline pigmentation, iris characteristics, ocular health and expectations influence clinical planning.
“Safety first, aesthetics within limits.”
Conservative strategies are prioritized when potential risk outweighs expected benefit. Not every patient is considered suitable for treatment.
Patients from different countries have sought medically guided information about lighter eye color. Goals may range from brown to hazel, green or blue-like tones. Education and expectation management remain central to the process.
Natural variations in iris pigmentation, baseline eye characteristics and non-surgical factors can affect perceived eye color. Treatment planning therefore remains conservative and individualized.
Educational resources address other approaches, including corneal-based procedures such as keratopigmentation and intraocular iris implants, together with their considerations and documented risks.
The MyLumineyes™ approach is presented in the context of scientific literature concerning iris pigmentation, melanin, photothermolysis, anterior segment safety and ophthalmic laser applications.
Independent scientific resources are provided for broader ophthalmic and scientific context and should not be interpreted as endorsement of a specific cosmetic procedure.
Patients may seek MyLumineyes™ not only because they want to change their eye color, but because they want to understand the procedure, its limitations and available alternatives.
Clear educational information about the clinical approach and treatment process.
Potential risks, limitations and situations in which treatment may not be appropriate.
Patient imagery and educational material intended to avoid exaggerated promises.
Dr. Mustafa Mete, an ophthalmologist focusing on iris pigmentation and anterior segment procedures, developed the MyLumineyes-Lumineyes™ method for selective laser iris depigmentation.
No. Patient selection is an important part of the clinical approach, and there are circumstances in which intervention may not be recommended.
No specific shade is promised for every patient. Baseline pigmentation, individual iris characteristics and other factors influence the visual result.
The starting point is an assessment of general eye health, iris structure, medical history and expectations. This helps determine whether a laser-based approach, another option or no intervention is more appropriate.
A consultation allows Dr. Mete to review medical history, assess ocular health and iris structure, discuss expectations and determine whether a laser-based approach, another option or no intervention would be more appropriate.
Clinical images are presented as educational examples of individual outcomes. Results vary according to baseline iris pigmentation, ocular characteristics and individual biological response.
This page is intended for educational and professional profile information. Clinical suitability, risks, benefits, alternatives and expected outcomes should be assessed individually by a qualified ophthalmologist.
Clinical assessment, individualized planning and realistic expectations form the starting point of the MyLumineyes™ approach.
Begin with a Clinical Assessment →
Lumineyes Assistant
×